Evidence map›Paper›PMID 27393519›Full record

ArticlePurinergic signalling2016

P2X

Seetal Chavda, Philip J Luthert, Thomas E Salt

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Purinergic signalling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Role of P2X7R in Retinal Diseases: A Review.Immunity, inflammation and disease · 2025
    Review
  2. Review
  3. Article
  4. P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Seetal ChavdaVisual Neuroscience, UCL Institute of Ophthalmology, London, EC1V 9EL, UK.
Philip J LuthertOcular Biology and Therapeutics, UCL Institute of Ophthalmology, London, EC1V 9EL, UK.
Thomas E SaltVisual Neuroscience, UCL Institute of Ophthalmology, London, EC1V 9EL, UK. T.Salt@ucl.ac.uk.
University College London · GBUCL Biomedical Research Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

P2X

Indexed as

Adenosine TriphosphateAnimalsElectroretinographyEvoked Potentials, VisualExcitatory Postsynaptic PotentialsGuanidinesMiceMice, Inbred C57BLPhotic StimulationPurinergic P2X Receptor AgonistsPurinergic P2X Receptor AntagonistsPyridinesQuinolinesReceptors, Purinergic P2X7RetinaTetrazoles2-cyano-1-((1S)-1-phenylethyl)-3-quinolin-5-ylguanidine3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateAdenosine TriphosphateGuanidinesPurinergic P2X Receptor AgonistsPurinergic P2X Receptor AntagonistsPyridinesQuinolinesReceptors, Purinergic P2X7TetrazolesAdenosine 5′-triphosphateNeuromodulationP2X7 receptorRetina

Identifiers

PMID27393519
PMCPMC5123999
OpenAlexW2463922432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.